SCHEMBL8103876

SCHEMBL8103876

Cc1ccc(ON)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.43
ALDH1A1 P00352 2/20 0.43
ACHE P22303 3/20 0.43
MRGPRX4 Q96LA9 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
NFE2L2 Q16236 1/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
HTR1A P08908 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
KIF11 P52732 1/20 0.36
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLC6A3 Q01959 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2A6 P11509 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25156760 0.82 ACHE (0.43) CYP3A4ALDH1A1ACHEMRGPRX4CA1
SCHEMBL13180059 0.82 CA1 (0.44) CYP3A4ALDH1A1ACHECA1CA2
SCHEMBL26493853 0.81 ACHE (0.46) CYP3A4ALDH1A1ACHEMRGPRX4CA1
SCHEMBL15280170 0.79 ACHE (0.44) CYP3A4ALDH1A1ACHEMRGPRX4CA1
SCHEMBL11883 0.79 ACHE (0.62) CYP3A4ALDH1A1ACHENFE2L2SMN1; SMN2
SCHEMBL15304701 0.78 ACHE (0.54) CYP3A4ALDH1A1ACHECA1CA2
SCHEMBL14449407 0.77 ACHE (0.43) CYP3A4ALDH1A1ACHEMRGPRX4CA1
SCHEMBL18377117 0.76 ALDH1A1 (0.46) CYP3A4ALDH1A1ACHECA1CA2
SCHEMBL16392368 0.76 IDO1 (0.48) ALDH1A1
SCHEMBL1174545 0.76 ACHE (0.41) CYP3A4ALDH1A1ACHEMRGPRX4CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008139941-A1 SUBSTITUTED IMIDAZOLE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-20 WO disclosed